Foster Group’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-3,554
Closed -$245K 280
2025
Q2
$245K Buy
3,554
+444
+14% +$30.2K 0.01% 220
2025
Q1
$216K Buy
+3,110
New +$257K 0.01% 207
2024
Q4
Sell
-2,203
Closed -$262K 204
2024
Q3
$262K Buy
2,203
+30
+1% +$4K 0.01% 171
2024
Q2
$310K Buy
2,173
+38
+2% +$5.04K 0.01% 159
2024
Q1
$274K Buy
+2,135
New +$254K 0.01% 165

Other funds holding NVO

Foster Group's NVO Position: Q3 2025 in Review

Foster Group sold out of Novo Nordisk (NVO) in Q3 2025, closing a stake of 3,554 shares — an estimated $245K sold.

Foster Group first reported a position in NVO in Q1 2024 and held it in 5 quarters. The position peaked at $310K in Q2 2024. 1,395 funds tracked by Wall St. Rank hold NVO as of Q3 2025.

  • Foster Group reported no remaining Novo Nordisk position as of Q3 2025 after selling out during the quarter.
  • Foster Group sold 3,554 Novo Nordisk shares in Q3 2025, an estimated $245K.
  • Foster Group first reported a position in Novo Nordisk in Q1 2024 and held it in 5 quarters.
  • Foster Group's Novo Nordisk position peaked at $310K in Q2 2024.
  • 1,395 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.

Based on Foster Group's 13F filing for Q3 2025, filed 14 Oct 2025.